Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different-dose remimazolam toisylate plus alfentanil for painless colonoscopy in obese adults
ChiCTR2200057652Phase 4Not yet recruiting
- Sponsor
- Jiaxing Second Hospital
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and alfentanil in None (3 arms), sponsored by Jiaxing Second Hospital. Primary endpoint: Sedation success rate. Planned start Feb 2022; status: not yet recruiting.
02
Drugs
remimazolamalfentanil
Beyond the preview
Go deeper on ChiCTR2200057652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057652.